Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris

Paris 75248

1 studies enrolling now · 2 studies all time

What they study most

ALK Fusion-positive Solid or CNS Tumors, Differentiated Thyroid Cancer (DTC), Osteosarcoma, Solid Malignant Tumors, Tumors

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors — Recruiting now
• Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma — Completed